NCT02164981View on ClinicalTrials.gov

A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia

PHASE2CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

May 1, 2015

Primary Completion Date

March 31, 2017

Study Completion Date

April 5, 2017

Conditions
Schizophrenia
Interventions
DRUG

sodium nitroprusside

intravenous

OTHER

Placebo

Placebo

Trial Locations (4)

10016

New York University Langone Medical Center/Bellevue Hospital, New York

11004

Zucker Hillside Hospital, Glen Oaks

02114

Schizophrenia Clinical Research Program, Massachusetts General Hospital, Boston

01605

University of Massachusetts Medical School, Worcester

All Listed Sponsors
collaborator

Stanley Medical Research Institute

OTHER

lead

Massachusetts General Hospital

OTHER

NCT02164981 - A Proof of Concept Study of Intravenous Sodium Nitroprusside in Adults With Symptomatic Schizophrenia | Biotech Hunter | Biotech Hunter